Patents
Literature
3 results about "Antihistamine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Antihistamines are drugs which treat allergic rhinitis and other allergies. Typically people take antihistamines as an inexpensive, generic, over-the-counter drug that can provide relief from nasal congestion, sneezing, or hives caused by pollen, dust mites, or animal allergy with few side effects. Antihistamines are usually for short-term treatment. Chronic allergies increase the risk of health problems which antihistamines might not treat, including asthma, sinusitis, and lower respiratory tract infection. Consultation of a medical professional is recommended for those who intend to take antihistamines for longer-term use.
Antihistamine compounds, methods for preparing them, and their use
An antihistamine compound having the structure of formula (I), a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of the antihistamine compound having the structure of formula (I) and a pharmaceutically acceptable salt thereof in the treatment of diseases such as seasonal / perennial allergic rhinitis, allergic conjunctivitis, and urticaria. JPEG2025519827000061.jpg85170
Owner:HC SYNTHETIC PHARMA CO LTD
Compositions and methods for treatment of obesity and metabolic disorders
PCT designated stageWO2026136641A1Organic active ingredientsMetabolism disorderNon steroid anti inflammatory drugAntiinflammatory drug
The present disclosure provides compositions, uses thereof, and methods for treating subjects with obesity and / or metabolic disorders. In aspects and embodiments, the method comprises administering an effective amount of one or more of a mast cell stabilizer and an H1-antihistamine, in combination with a non-steroidal anti-inflammatory drug (NSAID), either in the same or separate compositions.
Owner:SEN JAM PHARMACEUTICAL LLC
Method for improving atopic dermatitis by using a composition comprising low-molecular-weight fucoidan
PendingUS20260144814A1Organic active ingredientsDermatological disorderTopical steroidLiver and kidney
The present invention is a method for improving atopic dermatitis, comprising administering to a subject in need thereof a composition comprising a low-molecular-weight fucoidan (LMF), wherein the weight-average molecular weight of the LMF is less than 3,000 Daltons. The composition of the present invention can effectively improve the area and severity of the lesion in patients with AD, as well as the itching symptoms (including insomnia symptoms caused by itching), and can significantly improve the SCORAD index of patients with AD. In addition, the composition of the present invention can reduce the patient's dependence on topical steroid ointments and / or oral antihistamines and reduce the AD-related immune parameters without increasing the biochemical indices of liver and kidney. Therefore, the composition of the present invention can be both effective and safe in the treatment of AD.
Owner:HI Q MARINE BIOTECH INT